COVID-19 Impact on Global Oral Anti-Diabetic Drug Market Insights, Forecast to 2026
![](/report_cover/6975/covid-19-impact-on-global-oral-anti-diabetic-drug-market-insights-forecast-to-2026_en.gif)
Oral Anti-Diabetic Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Anti-Diabetic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oral Anti-Diabetic Drug market is segmented into
The Oral Anti-Diabetic Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oral Anti-Diabetic Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oral Anti-Diabetic Drug Market Share Analysis
Oral Anti-Diabetic Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Anti-Diabetic Drug business, the date to enter into the Oral Anti-Diabetic Drug market, Oral Anti-Diabetic Drug product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Oral Anti-Diabetic Drug market is segmented into
- Glimepiride
- Gliclazide
- Glyburide
- Others
- Hospital
- Research Institual
The Oral Anti-Diabetic Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oral Anti-Diabetic Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oral Anti-Diabetic Drug Market Share Analysis
Oral Anti-Diabetic Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Anti-Diabetic Drug business, the date to enter into the Oral Anti-Diabetic Drug market, Oral Anti-Diabetic Drug product introduction, recent developments, etc.
The major vendors covered:
- Takeda
- Pfizer
- Eli Lilly
- Janssen Pharmaceuticals
- Astellas
- Boehringer Ingelheim
- Merck And Co.
- AstraZeneca
- Bristol Myers Squibb
- Novartis
- Sanofi
- Abbott
- Biocon
1 STUDY COVERAGE
1.1 Oral Anti-Diabetic Drug Product Introduction
1.2 Market Segments
1.3 Key Oral Anti-Diabetic Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oral Anti-Diabetic Drug Market Size Growth Rate by Type
1.4.2 Glimepiride
1.4.3 Gliclazide
1.4.4 Glyburide
1.4.5 Others
1.5 Market by Application
1.5.1 Global Oral Anti-Diabetic Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Research Institual
1.6 Coronavirus Disease 2019 (Covid-19): Oral Anti-Diabetic Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Oral Anti-Diabetic Drug Industry
1.6.1.1 Oral Anti-Diabetic Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Oral Anti-Diabetic Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Oral Anti-Diabetic Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Oral Anti-Diabetic Drug Market Size Estimates and Forecasts
2.1.1 Global Oral Anti-Diabetic Drug Revenue 2015-2026
2.1.2 Global Oral Anti-Diabetic Drug Sales 2015-2026
2.2 Oral Anti-Diabetic Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global Oral Anti-Diabetic Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oral Anti-Diabetic Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ORAL ANTI-DIABETIC DRUG COMPETITOR LANDSCAPE BY PLAYERS
3.1 Oral Anti-Diabetic Drug Sales by Manufacturers
3.1.1 Oral Anti-Diabetic Drug Sales by Manufacturers (2015-2020)
3.1.2 Oral Anti-Diabetic Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Oral Anti-Diabetic Drug Revenue by Manufacturers
3.2.1 Oral Anti-Diabetic Drug Revenue by Manufacturers (2015-2020)
3.2.2 Oral Anti-Diabetic Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oral Anti-Diabetic Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oral Anti-Diabetic Drug Revenue in 2019
3.2.5 Global Oral Anti-Diabetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oral Anti-Diabetic Drug Price by Manufacturers
3.4 Oral Anti-Diabetic Drug Manufacturing Base Distribution, Product Types
3.4.1 Oral Anti-Diabetic Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Anti-Diabetic Drug Product Type
3.4.3 Date of International Manufacturers Enter into Oral Anti-Diabetic Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Oral Anti-Diabetic Drug Market Size by Type (2015-2020)
4.1.1 Global Oral Anti-Diabetic Drug Sales by Type (2015-2020)
4.1.2 Global Oral Anti-Diabetic Drug Revenue by Type (2015-2020)
4.1.3 Oral Anti-Diabetic Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oral Anti-Diabetic Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Oral Anti-Diabetic Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Anti-Diabetic Drug Revenue Forecast by Type (2021-2026)
4.2.3 Oral Anti-Diabetic Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oral Anti-Diabetic Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Oral Anti-Diabetic Drug Market Size by Application (2015-2020)
5.1.1 Global Oral Anti-Diabetic Drug Sales by Application (2015-2020)
5.1.2 Global Oral Anti-Diabetic Drug Revenue by Application (2015-2020)
5.1.3 Oral Anti-Diabetic Drug Price by Application (2015-2020)
5.2 Oral Anti-Diabetic Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Oral Anti-Diabetic Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Anti-Diabetic Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Anti-Diabetic Drug Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Oral Anti-Diabetic Drug by Country
6.1.1 North America Oral Anti-Diabetic Drug Sales by Country
6.1.2 North America Oral Anti-Diabetic Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oral Anti-Diabetic Drug Market Facts & Figures by Type
6.3 North America Oral Anti-Diabetic Drug Market Facts & Figures by Application
7 EUROPE
7.1 Europe Oral Anti-Diabetic Drug by Country
7.1.1 Europe Oral Anti-Diabetic Drug Sales by Country
7.1.2 Europe Oral Anti-Diabetic Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Anti-Diabetic Drug Market Facts & Figures by Type
7.3 Europe Oral Anti-Diabetic Drug Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Oral Anti-Diabetic Drug by Region
8.1.1 Asia Pacific Oral Anti-Diabetic Drug Sales by Region
8.1.2 Asia Pacific Oral Anti-Diabetic Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oral Anti-Diabetic Drug Market Facts & Figures by Type
8.3 Asia Pacific Oral Anti-Diabetic Drug Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Oral Anti-Diabetic Drug by Country
9.1.1 Latin America Oral Anti-Diabetic Drug Sales by Country
9.1.2 Latin America Oral Anti-Diabetic Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oral Anti-Diabetic Drug Market Facts & Figures by Type
9.3 Central & South America Oral Anti-Diabetic Drug Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Oral Anti-Diabetic Drug by Country
10.1.1 Middle East and Africa Oral Anti-Diabetic Drug Sales by Country
10.1.2 Middle East and Africa Oral Anti-Diabetic Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oral Anti-Diabetic Drug Market Facts & Figures by Type
10.3 Middle East and Africa Oral Anti-Diabetic Drug Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Takeda
11.1.1 Takeda Corporation Information
11.1.2 Takeda Description, Business Overview and Total Revenue
11.1.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Takeda Oral Anti-Diabetic Drug Products Offered
11.1.5 Takeda Recent Development
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description, Business Overview and Total Revenue
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Oral Anti-Diabetic Drug Products Offered
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Description, Business Overview and Total Revenue
11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly Oral Anti-Diabetic Drug Products Offered
11.3.5 Eli Lilly Recent Development
11.4 Janssen Pharmaceuticals
11.4.1 Janssen Pharmaceuticals Corporation Information
11.4.2 Janssen Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Janssen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Products Offered
11.4.5 Janssen Pharmaceuticals Recent Development
11.5 Astellas
11.5.1 Astellas Corporation Information
11.5.2 Astellas Description, Business Overview and Total Revenue
11.5.3 Astellas Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Astellas Oral Anti-Diabetic Drug Products Offered
11.5.5 Astellas Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Corporation Information
11.6.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.6.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Boehringer Ingelheim Oral Anti-Diabetic Drug Products Offered
11.6.5 Boehringer Ingelheim Recent Development
11.7 Merck And Co.
11.7.1 Merck And Co. Corporation Information
11.7.2 Merck And Co. Description, Business Overview and Total Revenue
11.7.3 Merck And Co. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck And Co. Oral Anti-Diabetic Drug Products Offered
11.7.5 Merck And Co. Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Description, Business Overview and Total Revenue
11.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AstraZeneca Oral Anti-Diabetic Drug Products Offered
11.8.5 AstraZeneca Recent Development
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Corporation Information
11.9.2 Bristol Myers Squibb Description, Business Overview and Total Revenue
11.9.3 Bristol Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bristol Myers Squibb Oral Anti-Diabetic Drug Products Offered
11.9.5 Bristol Myers Squibb Recent Development
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Description, Business Overview and Total Revenue
11.10.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novartis Oral Anti-Diabetic Drug Products Offered
11.10.5 Novartis Recent Development
11.1 Takeda
11.1.1 Takeda Corporation Information
11.1.2 Takeda Description, Business Overview and Total Revenue
11.1.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Takeda Oral Anti-Diabetic Drug Products Offered
11.1.5 Takeda Recent Development
11.12 Abbott
11.12.1 Abbott Corporation Information
11.12.2 Abbott Description, Business Overview and Total Revenue
11.12.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Abbott Products Offered
11.12.5 Abbott Recent Development
11.13 Biocon
11.13.1 Biocon Corporation Information
11.13.2 Biocon Description, Business Overview and Total Revenue
11.13.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Biocon Products Offered
11.13.5 Biocon Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Oral Anti-Diabetic Drug Market Estimates and Projections by Region
12.1.1 Global Oral Anti-Diabetic Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Oral Anti-Diabetic Drug Revenue Forecast by Regions 2021-2026
12.2 North America Oral Anti-Diabetic Drug Market Size Forecast (2021-2026)
12.2.1 North America: Oral Anti-Diabetic Drug Sales Forecast (2021-2026)
12.2.2 North America: Oral Anti-Diabetic Drug Revenue Forecast (2021-2026)
12.2.3 North America: Oral Anti-Diabetic Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Oral Anti-Diabetic Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Oral Anti-Diabetic Drug Sales Forecast (2021-2026)
12.3.2 Europe: Oral Anti-Diabetic Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Oral Anti-Diabetic Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oral Anti-Diabetic Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oral Anti-Diabetic Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oral Anti-Diabetic Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oral Anti-Diabetic Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Oral Anti-Diabetic Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Oral Anti-Diabetic Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Oral Anti-Diabetic Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Oral Anti-Diabetic Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oral Anti-Diabetic Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oral Anti-Diabetic Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oral Anti-Diabetic Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oral Anti-Diabetic Drug Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oral Anti-Diabetic Drug Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Oral Anti-Diabetic Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Oral Anti-Diabetic Drug Product Introduction
1.2 Market Segments
1.3 Key Oral Anti-Diabetic Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oral Anti-Diabetic Drug Market Size Growth Rate by Type
1.4.2 Glimepiride
1.4.3 Gliclazide
1.4.4 Glyburide
1.4.5 Others
1.5 Market by Application
1.5.1 Global Oral Anti-Diabetic Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Research Institual
1.6 Coronavirus Disease 2019 (Covid-19): Oral Anti-Diabetic Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Oral Anti-Diabetic Drug Industry
1.6.1.1 Oral Anti-Diabetic Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Oral Anti-Diabetic Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Oral Anti-Diabetic Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Oral Anti-Diabetic Drug Market Size Estimates and Forecasts
2.1.1 Global Oral Anti-Diabetic Drug Revenue 2015-2026
2.1.2 Global Oral Anti-Diabetic Drug Sales 2015-2026
2.2 Oral Anti-Diabetic Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global Oral Anti-Diabetic Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oral Anti-Diabetic Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ORAL ANTI-DIABETIC DRUG COMPETITOR LANDSCAPE BY PLAYERS
3.1 Oral Anti-Diabetic Drug Sales by Manufacturers
3.1.1 Oral Anti-Diabetic Drug Sales by Manufacturers (2015-2020)
3.1.2 Oral Anti-Diabetic Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Oral Anti-Diabetic Drug Revenue by Manufacturers
3.2.1 Oral Anti-Diabetic Drug Revenue by Manufacturers (2015-2020)
3.2.2 Oral Anti-Diabetic Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oral Anti-Diabetic Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oral Anti-Diabetic Drug Revenue in 2019
3.2.5 Global Oral Anti-Diabetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oral Anti-Diabetic Drug Price by Manufacturers
3.4 Oral Anti-Diabetic Drug Manufacturing Base Distribution, Product Types
3.4.1 Oral Anti-Diabetic Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Anti-Diabetic Drug Product Type
3.4.3 Date of International Manufacturers Enter into Oral Anti-Diabetic Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Oral Anti-Diabetic Drug Market Size by Type (2015-2020)
4.1.1 Global Oral Anti-Diabetic Drug Sales by Type (2015-2020)
4.1.2 Global Oral Anti-Diabetic Drug Revenue by Type (2015-2020)
4.1.3 Oral Anti-Diabetic Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oral Anti-Diabetic Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Oral Anti-Diabetic Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Anti-Diabetic Drug Revenue Forecast by Type (2021-2026)
4.2.3 Oral Anti-Diabetic Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oral Anti-Diabetic Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Oral Anti-Diabetic Drug Market Size by Application (2015-2020)
5.1.1 Global Oral Anti-Diabetic Drug Sales by Application (2015-2020)
5.1.2 Global Oral Anti-Diabetic Drug Revenue by Application (2015-2020)
5.1.3 Oral Anti-Diabetic Drug Price by Application (2015-2020)
5.2 Oral Anti-Diabetic Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Oral Anti-Diabetic Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Anti-Diabetic Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Anti-Diabetic Drug Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Oral Anti-Diabetic Drug by Country
6.1.1 North America Oral Anti-Diabetic Drug Sales by Country
6.1.2 North America Oral Anti-Diabetic Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oral Anti-Diabetic Drug Market Facts & Figures by Type
6.3 North America Oral Anti-Diabetic Drug Market Facts & Figures by Application
7 EUROPE
7.1 Europe Oral Anti-Diabetic Drug by Country
7.1.1 Europe Oral Anti-Diabetic Drug Sales by Country
7.1.2 Europe Oral Anti-Diabetic Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Anti-Diabetic Drug Market Facts & Figures by Type
7.3 Europe Oral Anti-Diabetic Drug Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Oral Anti-Diabetic Drug by Region
8.1.1 Asia Pacific Oral Anti-Diabetic Drug Sales by Region
8.1.2 Asia Pacific Oral Anti-Diabetic Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oral Anti-Diabetic Drug Market Facts & Figures by Type
8.3 Asia Pacific Oral Anti-Diabetic Drug Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Oral Anti-Diabetic Drug by Country
9.1.1 Latin America Oral Anti-Diabetic Drug Sales by Country
9.1.2 Latin America Oral Anti-Diabetic Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oral Anti-Diabetic Drug Market Facts & Figures by Type
9.3 Central & South America Oral Anti-Diabetic Drug Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Oral Anti-Diabetic Drug by Country
10.1.1 Middle East and Africa Oral Anti-Diabetic Drug Sales by Country
10.1.2 Middle East and Africa Oral Anti-Diabetic Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oral Anti-Diabetic Drug Market Facts & Figures by Type
10.3 Middle East and Africa Oral Anti-Diabetic Drug Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Takeda
11.1.1 Takeda Corporation Information
11.1.2 Takeda Description, Business Overview and Total Revenue
11.1.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Takeda Oral Anti-Diabetic Drug Products Offered
11.1.5 Takeda Recent Development
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description, Business Overview and Total Revenue
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Oral Anti-Diabetic Drug Products Offered
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Description, Business Overview and Total Revenue
11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly Oral Anti-Diabetic Drug Products Offered
11.3.5 Eli Lilly Recent Development
11.4 Janssen Pharmaceuticals
11.4.1 Janssen Pharmaceuticals Corporation Information
11.4.2 Janssen Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Janssen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Products Offered
11.4.5 Janssen Pharmaceuticals Recent Development
11.5 Astellas
11.5.1 Astellas Corporation Information
11.5.2 Astellas Description, Business Overview and Total Revenue
11.5.3 Astellas Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Astellas Oral Anti-Diabetic Drug Products Offered
11.5.5 Astellas Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Corporation Information
11.6.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.6.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Boehringer Ingelheim Oral Anti-Diabetic Drug Products Offered
11.6.5 Boehringer Ingelheim Recent Development
11.7 Merck And Co.
11.7.1 Merck And Co. Corporation Information
11.7.2 Merck And Co. Description, Business Overview and Total Revenue
11.7.3 Merck And Co. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck And Co. Oral Anti-Diabetic Drug Products Offered
11.7.5 Merck And Co. Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Description, Business Overview and Total Revenue
11.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AstraZeneca Oral Anti-Diabetic Drug Products Offered
11.8.5 AstraZeneca Recent Development
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Corporation Information
11.9.2 Bristol Myers Squibb Description, Business Overview and Total Revenue
11.9.3 Bristol Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bristol Myers Squibb Oral Anti-Diabetic Drug Products Offered
11.9.5 Bristol Myers Squibb Recent Development
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Description, Business Overview and Total Revenue
11.10.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novartis Oral Anti-Diabetic Drug Products Offered
11.10.5 Novartis Recent Development
11.1 Takeda
11.1.1 Takeda Corporation Information
11.1.2 Takeda Description, Business Overview and Total Revenue
11.1.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Takeda Oral Anti-Diabetic Drug Products Offered
11.1.5 Takeda Recent Development
11.12 Abbott
11.12.1 Abbott Corporation Information
11.12.2 Abbott Description, Business Overview and Total Revenue
11.12.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Abbott Products Offered
11.12.5 Abbott Recent Development
11.13 Biocon
11.13.1 Biocon Corporation Information
11.13.2 Biocon Description, Business Overview and Total Revenue
11.13.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Biocon Products Offered
11.13.5 Biocon Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Oral Anti-Diabetic Drug Market Estimates and Projections by Region
12.1.1 Global Oral Anti-Diabetic Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Oral Anti-Diabetic Drug Revenue Forecast by Regions 2021-2026
12.2 North America Oral Anti-Diabetic Drug Market Size Forecast (2021-2026)
12.2.1 North America: Oral Anti-Diabetic Drug Sales Forecast (2021-2026)
12.2.2 North America: Oral Anti-Diabetic Drug Revenue Forecast (2021-2026)
12.2.3 North America: Oral Anti-Diabetic Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Oral Anti-Diabetic Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Oral Anti-Diabetic Drug Sales Forecast (2021-2026)
12.3.2 Europe: Oral Anti-Diabetic Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Oral Anti-Diabetic Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oral Anti-Diabetic Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oral Anti-Diabetic Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oral Anti-Diabetic Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oral Anti-Diabetic Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Oral Anti-Diabetic Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Oral Anti-Diabetic Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Oral Anti-Diabetic Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Oral Anti-Diabetic Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oral Anti-Diabetic Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oral Anti-Diabetic Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oral Anti-Diabetic Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oral Anti-Diabetic Drug Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oral Anti-Diabetic Drug Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Oral Anti-Diabetic Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Oral Anti-Diabetic Drug Market Segments
Table 2. Ranking of Global Top Oral Anti-Diabetic Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oral Anti-Diabetic Drug Market Size Growth Rate by Type 2020-2026 (K Tons) & (US$ Million)
Table 4. Major Manufacturers of Glimepiride
Table 5. Major Manufacturers of Gliclazide
Table 6. Major Manufacturers of Glyburide
Table 7. Major Manufacturers of Others
Table 8. COVID-19 Impact Global Market: (Four Oral Anti-Diabetic Drug Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Oral Anti-Diabetic Drug Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Oral Anti-Diabetic Drug Players to Combat Covid-19 Impact
Table 13. Global Oral Anti-Diabetic Drug Market Size Growth Rate by Application 2020-2026 (K Tons)
Table 14. Global Oral Anti-Diabetic Drug Market Size by Region (K Tons) & (US$ Million): 2020 VS 2026
Table 15. Global Oral Anti-Diabetic Drug Sales by Regions 2015-2020 (K Tons)
Table 16. Global Oral Anti-Diabetic Drug Sales Market Share by Regions (2015-2020)
Table 17. Global Oral Anti-Diabetic Drug Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Oral Anti-Diabetic Drug Sales by Manufacturers (2015-2020) (K Tons)
Table 19. Global Oral Anti-Diabetic Drug Sales Share by Manufacturers (2015-2020)
Table 20. Global Oral Anti-Diabetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Oral Anti-Diabetic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Anti-Diabetic Drug as of 2019)
Table 22. Oral Anti-Diabetic Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Oral Anti-Diabetic Drug Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Oral Anti-Diabetic Drug Price (2015-2020) (USD/Ton)
Table 25. Oral Anti-Diabetic Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Oral Anti-Diabetic Drug Product Type
Table 27. Date of International Manufacturers Enter into Oral Anti-Diabetic Drug Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Oral Anti-Diabetic Drug Sales by Type (2015-2020) (K Tons)
Table 30. Global Oral Anti-Diabetic Drug Sales Share by Type (2015-2020)
Table 31. Global Oral Anti-Diabetic Drug Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Oral Anti-Diabetic Drug Revenue Share by Type (2015-2020)
Table 33. Oral Anti-Diabetic Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Ton)
Table 34. Global Oral Anti-Diabetic Drug Sales by Application (2015-2020) (K Tons)
Table 35. Global Oral Anti-Diabetic Drug Sales Share by Application (2015-2020)
Table 36. North America Oral Anti-Diabetic Drug Sales by Country (2015-2020) (K Tons)
Table 37. North America Oral Anti-Diabetic Drug Sales Market Share by Country (2015-2020)
Table 38. North America Oral Anti-Diabetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Oral Anti-Diabetic Drug Revenue Market Share by Country (2015-2020)
Table 40. North America Oral Anti-Diabetic Drug Sales by Type (2015-2020) (K Tons)
Table 41. North America Oral Anti-Diabetic Drug Sales Market Share by Type (2015-2020)
Table 42. North America Oral Anti-Diabetic Drug Sales by Application (2015-2020) (K Tons)
Table 43. North America Oral Anti-Diabetic Drug Sales Market Share by Application (2015-2020)
Table 44. Europe Oral Anti-Diabetic Drug Sales by Country (2015-2020) (K Tons)
Table 45. Europe Oral Anti-Diabetic Drug Sales Market Share by Country (2015-2020)
Table 46. Europe Oral Anti-Diabetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Oral Anti-Diabetic Drug Revenue Market Share by Country (2015-2020)
Table 48. Europe Oral Anti-Diabetic Drug Sales by Type (2015-2020) (K Tons)
Table 49. Europe Oral Anti-Diabetic Drug Sales Market Share by Type (2015-2020)
Table 50. Europe Oral Anti-Diabetic Drug Sales by Application (2015-2020) (K Tons)
Table 51. Europe Oral Anti-Diabetic Drug Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Oral Anti-Diabetic Drug Sales by Region (2015-2020) (K Tons)
Table 53. Asia Pacific Oral Anti-Diabetic Drug Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Oral Anti-Diabetic Drug Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Oral Anti-Diabetic Drug Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Oral Anti-Diabetic Drug Sales by Type (2015-2020) (K Tons)
Table 57. Asia Pacific Oral Anti-Diabetic Drug Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Oral Anti-Diabetic Drug Sales by Application (2015-2020) (K Tons)
Table 59. Asia Pacific Oral Anti-Diabetic Drug Sales Market Share by Application (2015-2020)
Table 60. Latin America Oral Anti-Diabetic Drug Sales by Country (2015-2020) (K Tons)
Table 61. Latin America Oral Anti-Diabetic Drug Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Oral Anti-Diabetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Oral Anti-Diabetic Drug Revenue Market Share by Country (2015-2020)
Table 64. Latin America Oral Anti-Diabetic Drug Sales by Type (2015-2020) (K Tons)
Table 65. Latin America Oral Anti-Diabetic Drug Sales Market Share by Type (2015-2020)
Table 66. Latin America Oral Anti-Diabetic Drug Sales by Application (2015-2020) (K Tons)
Table 67. Latin America Oral Anti-Diabetic Drug Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Oral Anti-Diabetic Drug Sales by Country (2015-2020) (K Tons)
Table 69. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Oral Anti-Diabetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Oral Anti-Diabetic Drug Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Oral Anti-Diabetic Drug Sales by Type (2015-2020) (K Tons)
Table 73. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Oral Anti-Diabetic Drug Sales by Application (2015-2020) (K Tons)
Table 75. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share by Application (2015-2020)
Table 76. Takeda Corporation Information
Table 77. Takeda Description and Major Businesses
Table 78. Takeda Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 79. Takeda Product
Table 80. Takeda Recent Development
Table 81. Pfizer Corporation Information
Table 82. Pfizer Description and Major Businesses
Table 83. Pfizer Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 84. Pfizer Product
Table 85. Pfizer Recent Development
Table 86. Eli Lilly Corporation Information
Table 87. Eli Lilly Description and Major Businesses
Table 88. Eli Lilly Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 89. Eli Lilly Product
Table 90. Eli Lilly Recent Development
Table 91. Janssen Pharmaceuticals Corporation Information
Table 92. Janssen Pharmaceuticals Description and Major Businesses
Table 93. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 94. Janssen Pharmaceuticals Product
Table 95. Janssen Pharmaceuticals Recent Development
Table 96. Astellas Corporation Information
Table 97. Astellas Description and Major Businesses
Table 98. Astellas Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 99. Astellas Product
Table 100. Astellas Recent Development
Table 101. Boehringer Ingelheim Corporation Information
Table 102. Boehringer Ingelheim Description and Major Businesses
Table 103. Boehringer Ingelheim Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 104. Boehringer Ingelheim Product
Table 105. Boehringer Ingelheim Recent Development
Table 106. Merck And Co. Corporation Information
Table 107. Merck And Co. Description and Major Businesses
Table 108. Merck And Co. Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 109. Merck And Co. Product
Table 110. Merck And Co. Recent Development
Table 111. AstraZeneca Corporation Information
Table 112. AstraZeneca Description and Major Businesses
Table 113. AstraZeneca Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 114. AstraZeneca Product
Table 115. AstraZeneca Recent Development
Table 116. Bristol Myers Squibb Corporation Information
Table 117. Bristol Myers Squibb Description and Major Businesses
Table 118. Bristol Myers Squibb Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 119. Bristol Myers Squibb Product
Table 120. Bristol Myers Squibb Recent Development
Table 121. Novartis Corporation Information
Table 122. Novartis Description and Major Businesses
Table 123. Novartis Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 124. Novartis Product
Table 125. Novartis Recent Development
Table 126. Sanofi Corporation Information
Table 127. Sanofi Description and Major Businesses
Table 128. Sanofi Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 129. Sanofi Product
Table 130. Sanofi Recent Development
Table 131. Abbott Corporation Information
Table 132. Abbott Description and Major Businesses
Table 133. Abbott Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 134. Abbott Product
Table 135. Abbott Recent Development
Table 136. Biocon Corporation Information
Table 137. Biocon Description and Major Businesses
Table 138. Biocon Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 139. Biocon Product
Table 140. Biocon Recent Development
Table 141. Global Oral Anti-Diabetic Drug Sales Forecast by Regions (2021-2026) (K Tons)
Table 142. Global Oral Anti-Diabetic Drug Sales Market Share Forecast by Regions (2021-2026)
Table 143. Global Oral Anti-Diabetic Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 144. Global Oral Anti-Diabetic Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 145. North America: Oral Anti-Diabetic Drug Sales Forecast by Country (2021-2026) (K Tons)
Table 146. North America: Oral Anti-Diabetic Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Europe: Oral Anti-Diabetic Drug Sales Forecast by Country (2021-2026) (K Tons)
Table 148. Europe: Oral Anti-Diabetic Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Asia Pacific: Oral Anti-Diabetic Drug Sales Forecast by Region (2021-2026) (K Tons)
Table 150. Asia Pacific: Oral Anti-Diabetic Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 151. Latin America: Oral Anti-Diabetic Drug Sales Forecast by Country (2021-2026) (K Tons)
Table 152. Latin America: Oral Anti-Diabetic Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Middle East and Africa: Oral Anti-Diabetic Drug Sales Forecast by Country (2021-2026) (K Tons)
Table 154. Middle East and Africa: Oral Anti-Diabetic Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 155. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 156. Key Challenges
Table 157. Market Risks
Table 158. Main Points Interviewed from Key Oral Anti-Diabetic Drug Players
Table 159. Oral Anti-Diabetic Drug Customers List
Table 160. Oral Anti-Diabetic Drug Distributors List
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 1. Oral Anti-Diabetic Drug Market Segments
Table 2. Ranking of Global Top Oral Anti-Diabetic Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oral Anti-Diabetic Drug Market Size Growth Rate by Type 2020-2026 (K Tons) & (US$ Million)
Table 4. Major Manufacturers of Glimepiride
Table 5. Major Manufacturers of Gliclazide
Table 6. Major Manufacturers of Glyburide
Table 7. Major Manufacturers of Others
Table 8. COVID-19 Impact Global Market: (Four Oral Anti-Diabetic Drug Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Oral Anti-Diabetic Drug Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Oral Anti-Diabetic Drug Players to Combat Covid-19 Impact
Table 13. Global Oral Anti-Diabetic Drug Market Size Growth Rate by Application 2020-2026 (K Tons)
Table 14. Global Oral Anti-Diabetic Drug Market Size by Region (K Tons) & (US$ Million): 2020 VS 2026
Table 15. Global Oral Anti-Diabetic Drug Sales by Regions 2015-2020 (K Tons)
Table 16. Global Oral Anti-Diabetic Drug Sales Market Share by Regions (2015-2020)
Table 17. Global Oral Anti-Diabetic Drug Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Oral Anti-Diabetic Drug Sales by Manufacturers (2015-2020) (K Tons)
Table 19. Global Oral Anti-Diabetic Drug Sales Share by Manufacturers (2015-2020)
Table 20. Global Oral Anti-Diabetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Oral Anti-Diabetic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Anti-Diabetic Drug as of 2019)
Table 22. Oral Anti-Diabetic Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Oral Anti-Diabetic Drug Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Oral Anti-Diabetic Drug Price (2015-2020) (USD/Ton)
Table 25. Oral Anti-Diabetic Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Oral Anti-Diabetic Drug Product Type
Table 27. Date of International Manufacturers Enter into Oral Anti-Diabetic Drug Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Oral Anti-Diabetic Drug Sales by Type (2015-2020) (K Tons)
Table 30. Global Oral Anti-Diabetic Drug Sales Share by Type (2015-2020)
Table 31. Global Oral Anti-Diabetic Drug Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Oral Anti-Diabetic Drug Revenue Share by Type (2015-2020)
Table 33. Oral Anti-Diabetic Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Ton)
Table 34. Global Oral Anti-Diabetic Drug Sales by Application (2015-2020) (K Tons)
Table 35. Global Oral Anti-Diabetic Drug Sales Share by Application (2015-2020)
Table 36. North America Oral Anti-Diabetic Drug Sales by Country (2015-2020) (K Tons)
Table 37. North America Oral Anti-Diabetic Drug Sales Market Share by Country (2015-2020)
Table 38. North America Oral Anti-Diabetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Oral Anti-Diabetic Drug Revenue Market Share by Country (2015-2020)
Table 40. North America Oral Anti-Diabetic Drug Sales by Type (2015-2020) (K Tons)
Table 41. North America Oral Anti-Diabetic Drug Sales Market Share by Type (2015-2020)
Table 42. North America Oral Anti-Diabetic Drug Sales by Application (2015-2020) (K Tons)
Table 43. North America Oral Anti-Diabetic Drug Sales Market Share by Application (2015-2020)
Table 44. Europe Oral Anti-Diabetic Drug Sales by Country (2015-2020) (K Tons)
Table 45. Europe Oral Anti-Diabetic Drug Sales Market Share by Country (2015-2020)
Table 46. Europe Oral Anti-Diabetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Oral Anti-Diabetic Drug Revenue Market Share by Country (2015-2020)
Table 48. Europe Oral Anti-Diabetic Drug Sales by Type (2015-2020) (K Tons)
Table 49. Europe Oral Anti-Diabetic Drug Sales Market Share by Type (2015-2020)
Table 50. Europe Oral Anti-Diabetic Drug Sales by Application (2015-2020) (K Tons)
Table 51. Europe Oral Anti-Diabetic Drug Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Oral Anti-Diabetic Drug Sales by Region (2015-2020) (K Tons)
Table 53. Asia Pacific Oral Anti-Diabetic Drug Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Oral Anti-Diabetic Drug Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Oral Anti-Diabetic Drug Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Oral Anti-Diabetic Drug Sales by Type (2015-2020) (K Tons)
Table 57. Asia Pacific Oral Anti-Diabetic Drug Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Oral Anti-Diabetic Drug Sales by Application (2015-2020) (K Tons)
Table 59. Asia Pacific Oral Anti-Diabetic Drug Sales Market Share by Application (2015-2020)
Table 60. Latin America Oral Anti-Diabetic Drug Sales by Country (2015-2020) (K Tons)
Table 61. Latin America Oral Anti-Diabetic Drug Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Oral Anti-Diabetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Oral Anti-Diabetic Drug Revenue Market Share by Country (2015-2020)
Table 64. Latin America Oral Anti-Diabetic Drug Sales by Type (2015-2020) (K Tons)
Table 65. Latin America Oral Anti-Diabetic Drug Sales Market Share by Type (2015-2020)
Table 66. Latin America Oral Anti-Diabetic Drug Sales by Application (2015-2020) (K Tons)
Table 67. Latin America Oral Anti-Diabetic Drug Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Oral Anti-Diabetic Drug Sales by Country (2015-2020) (K Tons)
Table 69. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Oral Anti-Diabetic Drug Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Oral Anti-Diabetic Drug Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Oral Anti-Diabetic Drug Sales by Type (2015-2020) (K Tons)
Table 73. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Oral Anti-Diabetic Drug Sales by Application (2015-2020) (K Tons)
Table 75. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share by Application (2015-2020)
Table 76. Takeda Corporation Information
Table 77. Takeda Description and Major Businesses
Table 78. Takeda Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 79. Takeda Product
Table 80. Takeda Recent Development
Table 81. Pfizer Corporation Information
Table 82. Pfizer Description and Major Businesses
Table 83. Pfizer Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 84. Pfizer Product
Table 85. Pfizer Recent Development
Table 86. Eli Lilly Corporation Information
Table 87. Eli Lilly Description and Major Businesses
Table 88. Eli Lilly Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 89. Eli Lilly Product
Table 90. Eli Lilly Recent Development
Table 91. Janssen Pharmaceuticals Corporation Information
Table 92. Janssen Pharmaceuticals Description and Major Businesses
Table 93. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 94. Janssen Pharmaceuticals Product
Table 95. Janssen Pharmaceuticals Recent Development
Table 96. Astellas Corporation Information
Table 97. Astellas Description and Major Businesses
Table 98. Astellas Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 99. Astellas Product
Table 100. Astellas Recent Development
Table 101. Boehringer Ingelheim Corporation Information
Table 102. Boehringer Ingelheim Description and Major Businesses
Table 103. Boehringer Ingelheim Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 104. Boehringer Ingelheim Product
Table 105. Boehringer Ingelheim Recent Development
Table 106. Merck And Co. Corporation Information
Table 107. Merck And Co. Description and Major Businesses
Table 108. Merck And Co. Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 109. Merck And Co. Product
Table 110. Merck And Co. Recent Development
Table 111. AstraZeneca Corporation Information
Table 112. AstraZeneca Description and Major Businesses
Table 113. AstraZeneca Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 114. AstraZeneca Product
Table 115. AstraZeneca Recent Development
Table 116. Bristol Myers Squibb Corporation Information
Table 117. Bristol Myers Squibb Description and Major Businesses
Table 118. Bristol Myers Squibb Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 119. Bristol Myers Squibb Product
Table 120. Bristol Myers Squibb Recent Development
Table 121. Novartis Corporation Information
Table 122. Novartis Description and Major Businesses
Table 123. Novartis Oral Anti-Diabetic Drug Production (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 124. Novartis Product
Table 125. Novartis Recent Development
Table 126. Sanofi Corporation Information
Table 127. Sanofi Description and Major Businesses
Table 128. Sanofi Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 129. Sanofi Product
Table 130. Sanofi Recent Development
Table 131. Abbott Corporation Information
Table 132. Abbott Description and Major Businesses
Table 133. Abbott Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 134. Abbott Product
Table 135. Abbott Recent Development
Table 136. Biocon Corporation Information
Table 137. Biocon Description and Major Businesses
Table 138. Biocon Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2015-2020)
Table 139. Biocon Product
Table 140. Biocon Recent Development
Table 141. Global Oral Anti-Diabetic Drug Sales Forecast by Regions (2021-2026) (K Tons)
Table 142. Global Oral Anti-Diabetic Drug Sales Market Share Forecast by Regions (2021-2026)
Table 143. Global Oral Anti-Diabetic Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 144. Global Oral Anti-Diabetic Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 145. North America: Oral Anti-Diabetic Drug Sales Forecast by Country (2021-2026) (K Tons)
Table 146. North America: Oral Anti-Diabetic Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Europe: Oral Anti-Diabetic Drug Sales Forecast by Country (2021-2026) (K Tons)
Table 148. Europe: Oral Anti-Diabetic Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Asia Pacific: Oral Anti-Diabetic Drug Sales Forecast by Region (2021-2026) (K Tons)
Table 150. Asia Pacific: Oral Anti-Diabetic Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 151. Latin America: Oral Anti-Diabetic Drug Sales Forecast by Country (2021-2026) (K Tons)
Table 152. Latin America: Oral Anti-Diabetic Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Middle East and Africa: Oral Anti-Diabetic Drug Sales Forecast by Country (2021-2026) (K Tons)
Table 154. Middle East and Africa: Oral Anti-Diabetic Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 155. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 156. Key Challenges
Table 157. Market Risks
Table 158. Main Points Interviewed from Key Oral Anti-Diabetic Drug Players
Table 159. Oral Anti-Diabetic Drug Customers List
Table 160. Oral Anti-Diabetic Drug Distributors List
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Oral Anti-Diabetic Drug Product Picture
Figure 2. Global Oral Anti-Diabetic Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Glimepiride Product Picture
Figure 4. Gliclazide Product Picture
Figure 5. Glyburide Product Picture
Figure 6. Others Product Picture
Figure 7. Global Oral Anti-Diabetic Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Research Institual
Figure 10. Oral Anti-Diabetic Drug Report Years Considered
Figure 11. Global Oral Anti-Diabetic Drug Market Size 2015-2026 (US$ Million)
Figure 12. Global Oral Anti-Diabetic Drug Sales 2015-2026 (K Tons)
Figure 13. Global Oral Anti-Diabetic Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Oral Anti-Diabetic Drug Sales Market Share by Region (2015-2020)
Figure 15. Global Oral Anti-Diabetic Drug Sales Market Share by Region in 2019
Figure 16. Global Oral Anti-Diabetic Drug Revenue Market Share by Region (2015-2020)
Figure 17. Global Oral Anti-Diabetic Drug Revenue Market Share by Region in 2019
Figure 18. Global Oral Anti-Diabetic Drug Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Oral Anti-Diabetic Drug Revenue in 2019
Figure 20. Oral Anti-Diabetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Oral Anti-Diabetic Drug Sales Market Share by Type (2015-2020)
Figure 22. Global Oral Anti-Diabetic Drug Sales Market Share by Type in 2019
Figure 23. Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2015-2020)
Figure 24. Global Oral Anti-Diabetic Drug Revenue Market Share by Type in 2019
Figure 25. Global Oral Anti-Diabetic Drug Market Share by Price Range (2015-2020)
Figure 26. Global Oral Anti-Diabetic Drug Sales Market Share by Application (2015-2020)
Figure 27. Global Oral Anti-Diabetic Drug Sales Market Share by Application in 2019
Figure 28. Global Oral Anti-Diabetic Drug Revenue Market Share by Application (2015-2020)
Figure 29. Global Oral Anti-Diabetic Drug Revenue Market Share by Application in 2019
Figure 30. North America Oral Anti-Diabetic Drug Sales Growth Rate 2015-2020 (K Tons)
Figure 31. North America Oral Anti-Diabetic Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Oral Anti-Diabetic Drug Sales Market Share by Country in 2019
Figure 33. North America Oral Anti-Diabetic Drug Revenue Market Share by Country in 2019
Figure 34. U.S. Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 35. U.S. Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 37. Canada Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Oral Anti-Diabetic Drug Market Share by Type in 2019
Figure 39. North America Oral Anti-Diabetic Drug Market Share by Application in 2019
Figure 40. Europe Oral Anti-Diabetic Drug Sales Growth Rate 2015-2020 (K Tons)
Figure 41. Europe Oral Anti-Diabetic Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Oral Anti-Diabetic Drug Sales Market Share by Country in 2019
Figure 43. Europe Oral Anti-Diabetic Drug Revenue Market Share by Country in 2019
Figure 44. Germany Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 45. Germany Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 47. France Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 49. U.K. Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 51. Italy Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 53. Russia Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Oral Anti-Diabetic Drug Market Share by Type in 2019
Figure 55. Europe Oral Anti-Diabetic Drug Market Share by Application in 2019
Figure 56. Asia Pacific Oral Anti-Diabetic Drug Sales Growth Rate 2015-2020 (K Tons)
Figure 57. Asia Pacific Oral Anti-Diabetic Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Oral Anti-Diabetic Drug Sales Market Share by Region in 2019
Figure 59. Asia Pacific Oral Anti-Diabetic Drug Revenue Market Share by Region in 2019
Figure 60. China Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 61. China Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 63. Japan Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 65. South Korea Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 67. India Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 69. Australia Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 71. Taiwan Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 73. Indonesia Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 75. Thailand Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 77. Malaysia Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 79. Philippines Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 81. Vietnam Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Oral Anti-Diabetic Drug Market Share by Type in 2019
Figure 83. Asia Pacific Oral Anti-Diabetic Drug Market Share by Application in 2019
Figure 84. Latin America Oral Anti-Diabetic Drug Sales Growth Rate 2015-2020 (K Tons)
Figure 85. Latin America Oral Anti-Diabetic Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Oral Anti-Diabetic Drug Sales Market Share by Country in 2019
Figure 87. Latin America Oral Anti-Diabetic Drug Revenue Market Share by Country in 2019
Figure 88. Mexico Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 89. Mexico Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 91. Brazil Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 93. Argentina Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Oral Anti-Diabetic Drug Market Share by Type in 2019
Figure 95. Latin America Oral Anti-Diabetic Drug Market Share by Application in 2019
Figure 96. Middle East and Africa Oral Anti-Diabetic Drug Sales Growth Rate 2015-2020 (K Tons)
Figure 97. Middle East and Africa Oral Anti-Diabetic Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Oral Anti-Diabetic Drug Revenue Market Share by Country in 2019
Figure 100. Turkey Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 101. Turkey Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 103. Saudi Arabia Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 105. U.A.E Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Oral Anti-Diabetic Drug Market Share by Type in 2019
Figure 107. Middle East and Africa Oral Anti-Diabetic Drug Market Share by Application in 2019
Figure 108. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Janssen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Astellas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Merck And Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Oral Anti-Diabetic Drug Sales Growth Rate Forecast (2021-2026) (K Tons)
Figure 122. North America Oral Anti-Diabetic Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Oral Anti-Diabetic Drug Sales Growth Rate Forecast (2021-2026) (K Tons)
Figure 124. Europe Oral Anti-Diabetic Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Oral Anti-Diabetic Drug Sales Growth Rate Forecast (2021-2026) (K Tons)
Figure 126. Asia Pacific Oral Anti-Diabetic Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Oral Anti-Diabetic Drug Sales Growth Rate Forecast (2021-2026) (K Tons)
Figure 128. Latin America Oral Anti-Diabetic Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Oral Anti-Diabetic Drug Sales Growth Rate Forecast (2021-2026) (K Tons)
Figure 130. Middle East and Africa Oral Anti-Diabetic Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed
Figure 1. Oral Anti-Diabetic Drug Product Picture
Figure 2. Global Oral Anti-Diabetic Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Glimepiride Product Picture
Figure 4. Gliclazide Product Picture
Figure 5. Glyburide Product Picture
Figure 6. Others Product Picture
Figure 7. Global Oral Anti-Diabetic Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Research Institual
Figure 10. Oral Anti-Diabetic Drug Report Years Considered
Figure 11. Global Oral Anti-Diabetic Drug Market Size 2015-2026 (US$ Million)
Figure 12. Global Oral Anti-Diabetic Drug Sales 2015-2026 (K Tons)
Figure 13. Global Oral Anti-Diabetic Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Oral Anti-Diabetic Drug Sales Market Share by Region (2015-2020)
Figure 15. Global Oral Anti-Diabetic Drug Sales Market Share by Region in 2019
Figure 16. Global Oral Anti-Diabetic Drug Revenue Market Share by Region (2015-2020)
Figure 17. Global Oral Anti-Diabetic Drug Revenue Market Share by Region in 2019
Figure 18. Global Oral Anti-Diabetic Drug Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Oral Anti-Diabetic Drug Revenue in 2019
Figure 20. Oral Anti-Diabetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Oral Anti-Diabetic Drug Sales Market Share by Type (2015-2020)
Figure 22. Global Oral Anti-Diabetic Drug Sales Market Share by Type in 2019
Figure 23. Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2015-2020)
Figure 24. Global Oral Anti-Diabetic Drug Revenue Market Share by Type in 2019
Figure 25. Global Oral Anti-Diabetic Drug Market Share by Price Range (2015-2020)
Figure 26. Global Oral Anti-Diabetic Drug Sales Market Share by Application (2015-2020)
Figure 27. Global Oral Anti-Diabetic Drug Sales Market Share by Application in 2019
Figure 28. Global Oral Anti-Diabetic Drug Revenue Market Share by Application (2015-2020)
Figure 29. Global Oral Anti-Diabetic Drug Revenue Market Share by Application in 2019
Figure 30. North America Oral Anti-Diabetic Drug Sales Growth Rate 2015-2020 (K Tons)
Figure 31. North America Oral Anti-Diabetic Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Oral Anti-Diabetic Drug Sales Market Share by Country in 2019
Figure 33. North America Oral Anti-Diabetic Drug Revenue Market Share by Country in 2019
Figure 34. U.S. Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 35. U.S. Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 37. Canada Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Oral Anti-Diabetic Drug Market Share by Type in 2019
Figure 39. North America Oral Anti-Diabetic Drug Market Share by Application in 2019
Figure 40. Europe Oral Anti-Diabetic Drug Sales Growth Rate 2015-2020 (K Tons)
Figure 41. Europe Oral Anti-Diabetic Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Oral Anti-Diabetic Drug Sales Market Share by Country in 2019
Figure 43. Europe Oral Anti-Diabetic Drug Revenue Market Share by Country in 2019
Figure 44. Germany Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 45. Germany Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 47. France Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 49. U.K. Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 51. Italy Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 53. Russia Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Oral Anti-Diabetic Drug Market Share by Type in 2019
Figure 55. Europe Oral Anti-Diabetic Drug Market Share by Application in 2019
Figure 56. Asia Pacific Oral Anti-Diabetic Drug Sales Growth Rate 2015-2020 (K Tons)
Figure 57. Asia Pacific Oral Anti-Diabetic Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Oral Anti-Diabetic Drug Sales Market Share by Region in 2019
Figure 59. Asia Pacific Oral Anti-Diabetic Drug Revenue Market Share by Region in 2019
Figure 60. China Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 61. China Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 63. Japan Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 65. South Korea Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 67. India Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 69. Australia Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 71. Taiwan Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 73. Indonesia Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 75. Thailand Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 77. Malaysia Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 79. Philippines Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 81. Vietnam Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Oral Anti-Diabetic Drug Market Share by Type in 2019
Figure 83. Asia Pacific Oral Anti-Diabetic Drug Market Share by Application in 2019
Figure 84. Latin America Oral Anti-Diabetic Drug Sales Growth Rate 2015-2020 (K Tons)
Figure 85. Latin America Oral Anti-Diabetic Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Oral Anti-Diabetic Drug Sales Market Share by Country in 2019
Figure 87. Latin America Oral Anti-Diabetic Drug Revenue Market Share by Country in 2019
Figure 88. Mexico Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 89. Mexico Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 91. Brazil Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 93. Argentina Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Oral Anti-Diabetic Drug Market Share by Type in 2019
Figure 95. Latin America Oral Anti-Diabetic Drug Market Share by Application in 2019
Figure 96. Middle East and Africa Oral Anti-Diabetic Drug Sales Growth Rate 2015-2020 (K Tons)
Figure 97. Middle East and Africa Oral Anti-Diabetic Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Oral Anti-Diabetic Drug Revenue Market Share by Country in 2019
Figure 100. Turkey Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 101. Turkey Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 103. Saudi Arabia Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Oral Anti-Diabetic Drug Sales Growth Rate (2015-2020) (K Tons)
Figure 105. U.A.E Oral Anti-Diabetic Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Oral Anti-Diabetic Drug Market Share by Type in 2019
Figure 107. Middle East and Africa Oral Anti-Diabetic Drug Market Share by Application in 2019
Figure 108. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Janssen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Astellas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Merck And Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Oral Anti-Diabetic Drug Sales Growth Rate Forecast (2021-2026) (K Tons)
Figure 122. North America Oral Anti-Diabetic Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Oral Anti-Diabetic Drug Sales Growth Rate Forecast (2021-2026) (K Tons)
Figure 124. Europe Oral Anti-Diabetic Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Oral Anti-Diabetic Drug Sales Growth Rate Forecast (2021-2026) (K Tons)
Figure 126. Asia Pacific Oral Anti-Diabetic Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Oral Anti-Diabetic Drug Sales Growth Rate Forecast (2021-2026) (K Tons)
Figure 128. Latin America Oral Anti-Diabetic Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Oral Anti-Diabetic Drug Sales Growth Rate Forecast (2021-2026) (K Tons)
Figure 130. Middle East and Africa Oral Anti-Diabetic Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed